1-63323324-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012183.3(FOXD3):c.266G>A(p.Gly89Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_012183.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXD3 | NM_012183.3 | c.266G>A | p.Gly89Glu | missense_variant | 1/1 | ENST00000371116.4 | NP_036315.1 | |
FOXD3-AS1 | NR_121637.1 | n.87+1031C>T | intron_variant, non_coding_transcript_variant | |||||
FOXD3-AS1 | NR_121636.1 | n.185+167C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXD3 | ENST00000371116.4 | c.266G>A | p.Gly89Glu | missense_variant | 1/1 | NM_012183.3 | ENSP00000360157 | P1 | ||
FOXD3-AS1 | ENST00000427268.1 | n.87+1031C>T | intron_variant, non_coding_transcript_variant | 1 | ||||||
FOXD3-AS1 | ENST00000431294.7 | n.286+167C>T | intron_variant, non_coding_transcript_variant | 1 | ||||||
FOXD3-AS1 | ENST00000697579.1 | n.203+149C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
FOXD3-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 22, 2023 | The FOXD3 c.266G>A variant is predicted to result in the amino acid substitution p.Gly89Glu. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.